Curcumin, a polyphenolic compound derived from dietary spice turmeric, possesses diverse pharmacologic effects including anti-inflammatory, antioxidant, antiproliferative and antiangiogenic activities. Phase I clinical trials have shown that curcumin is safe even at high doses (12 g/day) in humans but exhibit poor bioavailability. Major reasons contributing to the low plasma and tissue levels of curcumin appear to be due to poor absorption, rapid metabolism, and rapid systemic elimination. To improve the bioavailability of curcumin, numerous approaches have been undertaken. These approaches involve, first, the use of adjuvant like piperine that interferes with glucuronidation; second, the use of liposomal curcumin; third, curcumin nanoparticles; fourth, the use of curcumin phospholipid complex; and fifth, the use of structural analogues of curcumin (e.g., EF-24). The latter has been reported to have a rapid absorption with a peak plasma half-life. Despite the lower bioavailability, therapeutic efficacy of...

Bioavailability of curcumin: problems and promises.

Curcumin (diferuloylmethane) is a polyphenol derived from the plant Curcuma longa, commonly called turmeric. Extensive research over the last 50 years has indicated this polyphenol can both prevent and treat cancer. The anticancer potential of curcumin stems from its ability to suppress proliferation of a wide variety of tumor cells, down-regulate transcription factors NF- κB, AP-1 and Egr-1; down-regulate the expression of COX2, LOX, NOS, MMP-9, uPA, TNF, chemokines, cell surface adhesion molecules and cyclin D1; down-regulate growth factor receptors (such as EGFR and HER2); and inhibit the activity of c-Jun N-terminal kinase, protein tyrosine kinases and protein serine/threonine kinases. In several systems, curcumin has been described as a potent antioxidant and anti-inflammatory agent. Evidence has also been presented to suggest that curcumin can suppress tumor initiation, promotion and metastasis. Pharmacologically, curcumin has been found to be safe. Human clinical trials indicated no dose-limiting toxicity when administered at doses up to 10 g/day. All of these studies suggest that curcumin has enormous potential in the prevention and therapy of cancer. The current review describes in detail the data supporting these studies. Curcumin, derived from turmeric (vernacular name: Haldi), is a rhizome of the plant Curcuma longa. The medicinal use of this plant has been documented in Ayurveda (the Indian

Anticancer potential of curcumin: preclinical and clinical studies.

Curcumin as “Curecumin”: From kitchen to clinic

Curcumin is the active ingredient in the traditional herbal remedy and dietary spice turmeric (Curcuma longa). Curcumin has a surprisingly wide range of beneficial properties, including anti-inflammatory, antioxidant, chemopreventive and chemotherapeutic activity. The pleiotropic activities of curcumin derive from its complex chemistry as well as its ability to influence multiple signaling pathways, including survival pathways such as those regulated by NF-κB, Akt, and growth factors; cytoprotective pathways dependent on Nrf2; and metastatic and angiogenic pathways. Curcumin is a free radical scavenger and hydrogen donor, and exhibits both pro- and antioxidant activity. It also binds metals, particularly iron and copper, and can function as an iron chelator. Curcumin is remarkably non-toxic and exhibits limited bioavailability. Curcumin exhibits great promise as a therapeutic agent, and is currently in human clinical trials for a variety of conditions, including multiple myeloma, pancreatic cancer, myelodysplastic syndromes, colon cancer, psoriasis and Alzheimer’s disease.

/pdf/curcumin-from-ancient-medicine-to-current-clinical-trials-1qz017dco7.pdf

Curcumin: From ancient medicine to current clinical trials

Multiple biological activities of curcumin: a short review.

Anti-tumour and antioxidant activity of natural curcuminoids

Five synthetic curcuminoids and three natural curcuminoids were investigated for their antimutagenic and anti-promotional activity. The natural curcuminoids, curcumin I (diferuloylmethane), curcumin II (feruloyl- p -hydroxycin-namoylmethane) and curcumin III (bis-( p -hydroxycinnamoyl)methane) isolated from Curcuma longa were found to be potent inhibitors of mutagenesis and crotean oil-induced tumour promotion. Curcumin III produced 87.6% inhibition to 2-acetamidofluorene (2-AAF) induced mutagenesis, at a concentration of 100 μg/plate, curcumin II and curcumin I produced 70.5% and 68.3% inhibition at the same concentration. All the synthetic curcuminoids were found to inhibit 2-AAF-induced mutagenicity among which salicyl-and anisylcurcuminoids were the most active. Curcumin III was the most effective anti-promotor among natural curcuminoids. While 90% of the control animals were having papillomas on the 10th week of tumour initiation, only 10% of the curcumin III-treated animals, 20% of the curcumin II-treated animals, and 40% of the curcumin I-treated animals were having papillomas. Salicylcurcuminoid, which was causing no papillomas by the 10th week, was the most potent anti-carcinogen among the synthetic curcuminoids. Piperonal curcuminoid also exhibited anti-promotional activity.

Antimutagenic and anticarcinogenic activity of natural and synthetic curcuminoids

Anti-tumour and free radical scavenging activity of synthetic curcuminoids

The anti-inflammatory activity of three natural curcuminoids and eight synthetic curcuminoids was studied using the mouse paw oedema method.



Among the natural curcuminoids, curcumin III was the most effective anti-inflammatory agent. Curcumin III produced an inhibition of 86·8% of the mice paw oedema at a concentration of 50 mg kg−1 body weight whereas curcumin I and curcumin II produced an inhibition of 72·4% and 65·1%, respectively at the same concentration. Among the synthetic curcuminoids, salicyl (63·0% inhibition), veratryl (62·6%) and piperonal (61·1%) curcuminoids were found to be potent anti-inflammatory agents, followed by p-anisyl curcuminoid (58·6%).



There was a correlation between the anti-inflammatory activities of the curcuminoids and their observed antioxidant activities, reported earlier.

Anti‐inflammatory Activity of Natural and Synthetic Curcuminoids

Simultaneous stirring and microwave assisted synthesis of nanoflakes MnO2/rGO composite electrode material for symmetric supercapacitor with enhanced electrochemical performance

K.V. Dinesh Babu

Papers

Anti-tumour and antioxidant activity of natural curcuminoids

Antimutagenic and anticarcinogenic activity of natural and synthetic curcuminoids

Anti-tumour and free radical scavenging activity of synthetic curcuminoids

Anti‐inflammatory Activity of Natural and Synthetic Curcuminoids

Simultaneous stirring and microwave assisted synthesis of nanoflakes MnO2/rGO composite electrode material for symmetric supercapacitor with enhanced electrochemical performance